LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Learn More About Afferent Pharmaceuticals
Afferent Pharmaceuticals
image
First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next